Cargando…

What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes

Accurate delineation of clinical target volume (CTV) is critical in the effective management of squamous cell carcinoma (SCC) of esophagus using radiation therapy. Accurate delineation may improve the probability of local control and reduce the risk of complications. However, there are no consistent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Dali, Yuan, Yinping, Song, Xuqing, Yu, Yonghua, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716853/ https://www.ncbi.nlm.nih.gov/pubmed/26819644 http://dx.doi.org/10.7150/jca.13873

Ejemplares similares

Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT
por: Han, Dali, et al.
Publicado: (2019)

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
por: Zhu, Yingming, et al.
Publicado: (2016)

Cytokines Association with Clinical and Pathological Changes in Esophageal Squamous Cell Carcinoma
por: Diakowska, Dorota
Publicado: (2013)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

The Predictive Value of Tumor Volume and Its Change on Short-Term Outcome for Esophageal Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
por: Liang, Shuai, et al.
Publicado: (2021)

Editorial: Debates in clinical management in pediatric endocrinology, volume II
por: De Filippo, Gianpaolo, et al.
Publicado: (2023)

Parkinson’s Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
por: Jenner, Peter, et al.
Publicado: (2013)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

What is a clinical pathway? Development of a definition to inform the debate
por: Kinsman, Leigh, et al.
Publicado: (2010)

A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
por: Abdi, Hengameh, et al.
Publicado: (2020)

Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Lee, Tae Hoon, et al.
Publicado: (2022)

Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition
por: Yu, Jing, et al.
Publicado: (2019)

Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis
por: Wang, Qiang, et al.
Publicado: (2019)

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021)

The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
por: Song, Ge, et al.
Publicado: (2017)

Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
por: Huang, Ren-Wen, et al.
Publicado: (2014)

Pro/con clinical debate: Is high-volume hemofiltration beneficial in the treatment of septic shock?
por: Reiter, Karl, et al.
Publicado: (2002)

Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma
por: Yang, Ying, et al.
Publicado: (2017)

Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
por: Ai, Dashan, et al.
Publicado: (2023)

Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma
por: Wang, Shuai, et al.
Publicado: (2018)

Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma
por: Wang, Peng, et al.
Publicado: (2021)

Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
por: Zhang, Jingze, et al.
Publicado: (2018)

Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma
por: Hui, Marco K. C., et al.
Publicado: (2012)

Expression and clinical significance of Apollon in esophageal squamous cell carcinoma
por: Li, Rong, et al.
Publicado: (2016)

Assessment of sublingual microcirculation in critically ill patients: consensus and debate
por: Dilken, Olcay, et al.
Publicado: (2020)

Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
por: Tian, Dong, et al.
Publicado: (2020)

Debatable Tumours in Human and Animal Pathology
Publicado: (1941)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Commentary: Funneling the funnel chest debates into appropriate management of adult pectus excavatum
por: Abbas, Abbas E.
Publicado: (2022)

The expression of p‐p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance
por: Wang, Zhe, et al.
Publicado: (2019)

What is an appropriate strategy of conversion surgery for cT4b thoracic esophageal cancer?
por: Ozawa, Soji
Publicado: (2021)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume
por: Cui, Tiantian, et al.
Publicado: (2021)

Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
por: Zhao, Jian, et al.
Publicado: (2019)

The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis
por: Businello, Gianluca, et al.
Publicado: (2020)

The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
por: Zhang, Ying, et al.
Publicado: (2014)

Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma
por: Liu, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tlbma4b2he27hf3jp44hut613k